Delivery Order SPE2DB20D3103-SPE2DB22FN4S3

Award Date 4/27/22
Potential Completion Date 4/28/22
Potential Value $2.5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $4,300.40 firm fixed-price delivery order is for the supply of 1,000 mg/100 ml vials of the pharmaceutical product Diprivan. The award has no set-aside designation, indicating full and open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,566,633,078 units of the drug Diprivan 500 mg/50 ml vial. The fixed-price delivery order, valued at $2,952.46, was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that provides medical supplies to military healthcare facilities. The contract has an ultimate completion date of December 9, 2024 and was awarded on December 6, 2024. There was...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,709.70 firm fixed-price delivery order is for the supply of 4,560,521,815 units of the drug Diprivan (1,000 mg/100 ml vial, 100 ml) with an ultimate completion date of April 10, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This contract award, valued at $2,507.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Diprivan 200 mg/20 ml vials, with an ultimate completion date of November 4, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which provides a...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,360.24 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,566,186,094 units of Diprivan 1,000 mg/100 ml vials, a critical anesthetic medication. This delivery order is part of AmerisourceBergen's broader $999,999,999 Indefinite Delivery Contract with the DLA Troop...
This federal contract award, valued at $2,161.86, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,564,436,652 units of the pharmaceutical product DIPRIVAN 1,000 MG/100 ML VIAL 100ML. This is a firm fixed-price delivery order with an ultimate completion date of April 30, 2024. Amerisourcebergen, as a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,575.37 delivery order contract is for the supply of DIPRIVAN 500 MG/50 ML VIAL 50ML, a pharmaceutical product, with a period of performance through October 11, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, with ID SPE2DX15D3012|SPE2DX24F8FN3, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,006.75 firm fixed price delivery order is for 4,563,095,698 units of the anesthetic drug Diprivan 1,000 mg/100 ml vial, with a completion date of December 14, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
The federal contract award describes a delivery order (SPE2DB24FTJ91) issued to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) for the supply of the pharmaceutical product Diprivan (1,000 mg/100 ml vial, 100 ml). The contract has a firm fixed price of $2,510.52 and a period of performance through November 2, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a wide range of medical products and supplies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,100.30 firm fixed-price delivery order is for the supply of DIPRIVAN, a 1,000 mg/100 ml vial of the anesthetic medication. The contract has an ultimate completion date of July 26, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB22FN4S3
    Delivery Order

This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Diprivan 1,000 mg/100 ml vials. The $2,529.31 firm fixed price Delivery Order was issued by the Defense Logistics Agency (DLA) and has an ultimate completion date of April 28, 2022.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. Additionally, Amerisourcebergen maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 11:04 AM